Loading...
Dernières publications
-
Fanny Roth, Jamila Dhiab, Alexis Boulinguiez, Hadidja-Rose Mouigni, Saskia Lassche, et al.. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy. Acta Neuropathologica, 2022, ⟨10.1007/s00401-022-02503-7⟩. ⟨hal-03832636⟩
-
Elisa Negroni, Maria Kondili, Laura Muraine, Mona Bensalah, Gillian Sandra Butler-Browne, et al.. Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their “virtual” secretome. Frontiers in Cell and Developmental Biology, 2022, 10, ⟨10.3389/fcell.2022.952041⟩. ⟨hal-03830589⟩
-
Ingo Riederer, Daniella Arêas Mendes-Da-Cruz, Guilherme Cordenonsi da Fonseca, Mariela Natacha González, Otavio Brustolini, et al.. Zika virus disrupts gene expression in human myoblasts and myotubes: Relationship with susceptibility to infection. PLoS Neglected Tropical Diseases, 2022, 16 (2), pp.e0010166. ⟨10.1371/journal.pntd.0010166⟩. ⟨hal-03832616⟩
Chiffres clés
98
Publications avec texte intégral
Open Access
59 %
Mots clés
C2C12 cells
Dystrophie musculaire oculopharyngée
Autologous
Myosin
Andermann syndrome
Myogenesis
Adipose tissue
AAV
Myotube
OPMD
Xenograft
Anti-acetylcholine receptor antibodies
AAV vectors
Intercellular communication
Sarcopenia
Arbovirus
Geriatric assessment
Antisens oligonucleotides
Bile salt hydrolases
Alphavirus
Dysferlin
Functional genomics
Aged
Muscle
Fibrosis
DUX4
Oculopharyngeal muscular dystrophy
Accelerometry
Myopathies
Skeletal muscle
Cross-bridge kinetics
FAPs
PABPN1
Ageing
Muscle dystrophy
Alzheimer's disease
Duchenne muscular dystrophy
Cell therapy
Gene therapy
Satellite cell
APOPTOSIS
Inflammation
Triplet expansion disease
Biomarker
Actin
Muscle strength
2-D PAGE
Dysferlinopathy
CNOT6L
Human
Pax7
FSHD
Bioinformatics
Pharyngeal muscle
Neuromuscular junction NMJ
Nuclear envelope
Haploinsufficiency
CS
Myoblasts
Bioinformatique
Dystrophin
Myoblast
C2 domains
DNA methylation
Biopsies humaines
Regeneration
MUTATIONS
Agrégats de PABPN1
AChR antibodies
Muscle fibrosis
RNA
Annexin A2
PABPN1 agregates
BINDING SPECIFICITY
AUTOPHAGY
Lamins
Transcriptomics
GENE
Satellite cells
Antiserum
Myositis
Muscle stem cells
Autoimmune diseases
Aav-U7
Myopathy
Metabolism
ARN
Anti-fibrotic pharmacotherapies
Calcium
DMD
Differentiation
Thérapie génique
Gene replacement
Akt
CD49d
Exon-skipping
Botulinum neurotoxin
ALS
Aggregate
Atrophy